Holen Sie sich die Stockscreener-App
28.82
3.48%
0.97
Schlusskurs vom Vortag:
$27.85
Offen:
$27.85
24-Stunden-Volumen:
1.65M
Relative Volume:
2.05
Marktkapitalisierung:
$1.49B
Einnahmen:
$412.82M
Nettoeinkommen (Verlust:
$-8.19M
KGV:
-187.02
EPS:
-0.1541
Netto-Cashflow:
$64.17M
1W Leistung:
+10.08%
1M Leistung:
+33.80%
6M Leistung:
+47.95%
1J Leistung:
+49.40%
1-Tages-Spanne:
$27.76
$29.07
1-Wochen-Bereich:
$24.50
$29.07
52-Wochen-Spanne:
$10.96
$29.07
Caredx Inc Stock (CDNA) Company Profile
Firmenname
Caredx Inc
Sektor
Branche
Telefon
415-287-2300
Adresse
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, IDXX, A, NTRA
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
28.82 | 1.44B | 412.82M | -8.19M | 64.17M | -0.1541 |
TMO
Thermo Fisher Scientific Inc
|
513.03 | 187.95B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.19 | 136.75B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
551.50 | 43.78B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
136.01 | 38.27B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
261.91 | 37.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-06 | Herabstufung | Craig Hallum | Buy → Hold |
| 2025-08-26 | Eingeleitet | William Blair | Mkt Perform |
| 2025-01-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Underweight |
| 2024-08-19 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-05-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | Hochstufung | Craig Hallum | Hold → Buy |
| 2023-11-09 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-03-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2023-03-03 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2021-07-20 | Fortgesetzt | BTIG Research | Buy |
| 2021-06-03 | Eingeleitet | Goldman | Buy |
| 2021-02-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-02 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-26 | Eingeleitet | BTIG Research | Buy |
| 2020-06-19 | Bestätigt | H.C. Wainwright | Buy |
| 2019-10-01 | Fortgesetzt | Craig Hallum | Buy |
| 2019-05-09 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | Eingeleitet | Jefferies | Buy |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-09-18 | Bestätigt | H.C. Wainwright | Neutral |
| 2017-11-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-06-14 | Bestätigt | Mizuho | Buy |
| 2015-09-29 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | Eingeleitet | Craig Hallum | Buy |
| 2015-03-18 | Bestätigt | Mizuho | Buy |
Alle ansehen
Caredx Inc Aktie (CDNA) Neueste Nachrichten
1K9 Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of CareDx, Inc. – BOATS:CDNA - TradingView
Price to earnings forward of CareDx, Inc. – BOATS:CDNA - TradingView
CDNA Forecast — Price Target — Prediction for 2027 - TradingView
CareDx, Inc. Actuals & Estimates (NASDAQ:CDNA) - TradingView
CareDx Inc (CDNA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Caredx Inc stock hits 52-week high at 26.7 USD - Investing.com
Caredx Inc stock hits 52-week high at 26.7 USD By Investing.com - Investing.com Canada
CareDx Inc (CDNA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CareDx's CEO Sells 17K Shares - Yahoo Finance
CareDx (CDNA) Stock Could Be 1.5% Overvalued After AlloSure Study Buzz - Sahm
Responsive Playbooks and the CDNA Inflection - Stock Traders Daily
CareDx (NASDAQ:CDNA) Passes Both the Minervini Trend Template and High Growth Momentum Tests - ChartMill
CareDx (CDNA) Moves 11.5% Higher: Will This Strength Last? - Yahoo Finance
CareDx Inc (CDNA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CareDx Inc (CDNA) Institutional Confidence - TradingKey
CareDx Inc (CDNA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CareDx (CDNA) Showcases Innovations at American Transplant Congr - GuruFocus
CareDx Inc (CDNA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CareDx presents transplant monitoring data at medical congress - Investing.com
CareDx presents transplant monitoring data at medical congress By Investing.com - Investing.com Nigeria
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress - Business Wire
How New AlloSure Kidney Prognostic Evidence At CareDx (CDNA) Has Changed Its Investment Story - Sahm
Insider Sell: CareDx Inc (CDNA) President and CEO Hanna John Wal - GuruFocus
CareDx Inc (CDNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CareDx Inc (CDNA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CareDx Inc (CDNA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CareDx (CDNA) CEO sells 17,683 shares under 10b5-1 plan - Stock Titan
CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology - BioSpace
Insider Sell: Hannah Valantine Sells 12,103 Shares of CareDx Inc (CDNA) - GuruFocus
CareDx director Hannah Valantine sells $279,728 in stock By Investing.com - Investing.com India
CareDx director Hannah Valantine sells $279,728 in stock - Investing.com UK
New Analysis from CareDx (CDNA) Highlights Allograft Outcomes - GuruFocus
CareDx Inc (CDNA) Shares Fall 3.4% -- GF Value Says Still Overva - GuruFocus
Caredx Insider Sold Shares Worth $279,728, According to a Recent SEC Filing - marketscreener.com
CareDx (CDNA) director logs RSU grant and pre-planned share sale - Stock Titan
CareDx (CDNA) director receives 9,795-share RSU grant, holdings reach 58,943 - Stock Titan
CareDx (NASDAQ: CDNA) grants 9,795 RSUs to board member Riggsbee - Stock Titan
CareDx (CDNA) director Fred E. Cohen receives 9,795-share RSU grant - Stock Titan
CareDx (CDNA) director receives 9,795 RSUs in equity grant - Stock Titan
Director George Bickerstaff receives 9,795 RSUs at CareDx (NASDAQ: CDNA) - Stock Titan
CareDx (CDNA) director awarded 9,795 restricted stock units - Stock Titan
CareDx Shareholders Back Directors, Auditor and Equity Plan - The Globe and Mail
CareDx study links kidney test elevations to graft loss risk By Investing.com - Investing.com Nigeria
CareDx study links kidney test elevations to graft loss risk - Investing.com UK
CareDx sharpens precision diagnostics push with Naveris deal, AlloHeme plans - MSN
CareDx, Inc. Approves Amendment to 2024 Equity Incentive Plan and Reports 2026 Annual Meeting Results - Minichart
CareDx president and CEO John Hanna sells $528,442 in company stock - Investing.com India
CareDx president and CEO John Hanna sells $528,442 in company stock By Investing.com - Investing.com South Africa
CareDx shareholders approve equity plan amendment and elect directors at annual meeting - Investing.com Nigeria
Caredx Insider Sold Shares Worth $528,443, According to a Recent SEC Filing - Moomoo
Finanzdaten der Caredx Inc-Aktie (CDNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Caredx Inc-Aktie (CDNA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Valantine Hannah | Director |
Jun 15 '26 |
Sale |
23.11 |
12,103 |
279,728 |
36,686 |
| Hanna John Walter JR | President and CEO |
Jun 11 '26 |
Sale |
24.02 |
21,998 |
528,443 |
649,642 |
1.76%
0.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):